 Provider News CaliforniaSeptember 2023 Provider Newsletter Contents
CABC-CDCRCM-035536-23 Carelon Medical Benefits Management, Inc. is an independent company providing utilization management services on behalf of the health plan. Availity, LLC is an independent company providing administrative support services on behalf of the health plan. We ask that you review your online provider directory information on a regular basis to ensure it is correct. Access your information by visiting anthem.com/ca/provider, then under Provider Overview, choose Find Care. The Consolidated Appropriations Act (CAA) of 2021 contains a provision that requires online provider directory information be reviewed and updated as needed at least every 90 days. By reviewing your information regularly, you help us ensure your online provider directory information is current. Submit updates and corrections to your directory information by following the instructions on our Provider Maintenance webpage. We will send you an email acknowledging receipt of your request. Online update options include: - Add/change an address location.
- Name change.
- Provider leaving a group or a single location.
- Phone/fax number changes.
- Closing a practice location.
CABC-CM-034853-23-CPN34821 As part of our ongoing quality improvement efforts, we want you to know that some review requests may require documentation to substantiate the attestations that support the clinical appropriateness of the request. This documentation can be uploaded during the intake process. When requested, providers must submit such documentation from the patient’s medical record. If medical necessity is not supported through documents submitted, the request may be denied as not medically necessary. Such documentation is limited to what has been asserted via the prior authorization (PA) review attestations. If the request would be denied as not medically necessary, providers can participate in a PA discussion with an Carelon Medical Benefits Management physician reviewer. * Carelon Medical Benefits Management, Inc. is an independent company providing utilization management services on behalf of the health plan. CABC-CM-034177-23-CPN34175 Please find the updated Non-Emergent Medical Transportation Physician Certification Statement (NEMT PCS) Form and instructions to submit the form at Provider Forms under For Providers. During the COVID-19 public health emergency, Medicaid and Children’s Health Insurance Program (CHIP) members were able to stay enrolled in their current health coverage regardless of changes in eligibility or status. As Medicaid renewals begin again, your Medicaid and CHIP patients may have to take additional steps, which could include finding a new health plan. Patients who are receiving specialized care for medical conditions such as but not limited to pregnancy, chemotherapy, radiation therapy, or behavioral health therapy, may have additional concerns. They could be in the middle of treatment, scheduled for treatment, or on maintenance medications — and may be worried that they might lose access to their current care provider if they change health plans. The need for continuity of care in this changing landscapeWe’re committed to ensuring a smooth transition for your Medicaid and CHIP patients who are changing health plans. Our Continuity of Care/Transition of Care management team coordinates with you and your patients to ensure access to ongoing care. This includes a personalized evaluation of the member’s condition and network benefits to coordinate and minimize disruption of ongoing care: - Your patients can contact the number on the back of their member ID card and ask about our Transition of Care form. Once filled out, one of our dedicated nurse care managers will contact them to review their specialized care needs within 15 business days.
- Download our provider manual to learn more about our Continuity of Care/Transition of Care Program. Refer to the table of contents and find Continuity of Care/Transition of Care Program under the Quality Improvement Program section.
A proactive approach to prior authorizationsFor patients with CarelonRx, Inc.* as their pharmacy benefit manager and who are on maintenance medications or other medications for treatment, their existing, approved prior authorizations will automatically transfer to their new Anthem individual and family health plan, and there will be a one-time prior authorization applied for nonformulary medications. This will allow your patients to continue to fill their current medications and allow additional time to initiate the prior authorization process for any formulary differences. You and your patients can count on us for supportYour patients who are receiving specialized care may have concerns about continuing their care and staying with their current care providers. We want you to feel confident you have resources and answers to guide them. Together, we can ease your patients’ potential concerns and ensure a smooth transition for those who choose an Anthem individual and family health plan. If you would like more information, contact your Provider Relationship Management representative, or call the number on the back of the patient’s ID card. * CarelonRx, Inc. is an independent company providing pharmacy benefit management services on behalf of the health plan. CABC-CDCM-026682-23-CPN26000 Starting mid-September, search for patient information in Availity Essentials* Eligibility and Benefits without having a member ID. We’ve updated and streamlined the process to eliminate the need for the member ID while maintaining the highest HIPAA standards. Easily search for patient eligibility and benefits details using the Patient Search option of patient last name, patient first name, date of birth, and patient zip code. Find Eligibility and Benefits Inquiry on Availity’s top menu bar under Patient Registration. Once it becomes available, make sure to use the new search feature when you need to find member information and do not have access to the member ID. Need the member ID for another capability in Availity Essentials? When you use the new search option in Eligibility and Benefits Inquiry and see the eligibility and benefits details, the member’s current ID details will be available and allow you to transact within other digital capabilities where the member ID is required. Watch for more information on the Availity Essentials home page under News and Announcements to notify you when this feature is available. Get access to Availity Essentials nowIf you and your organization aren’t currently registered for Availity Essentials, now is the time to make that happen. Availity Essentials offers secure online access for working together and is free to our providers. To register, visit the availity.com Registration Information page. * Availity, LLC is an independent company providing administrative support services on behalf of the health plan. CABC-CM-025688-23-CPN25562 Digital Request for Additional Information (Digital RFAI) is the fastest and easiest way to get us the documents we need to process your claim. Now, it is even better! We’ve added filter, sort, and search features for greater productivity. New filtering functions are ideal for organizations where more than one person is responsible for submitting claim attachments. Another great feature: your filters are saved (locked) – so you can see your desired filter view each time you log on but easily clear them when your search criteria changes.

We are committed to shared success and reporting is just another way we are giving Digital RFAI users a productivity boost. We’ve added reporting fields that can be used for both History and Inbox reports. Fields available for History and Inbox reports
Expanded reporting fields are downloadable! Use the download option to meet your specific reporting requirements. 
We’re here to help! Want to know more about receiving digital notifications for faster claims processing? Visit the Digital RFAI learning microsite or reach out to your Provider Relations Account Manager. CABC-CM-035613-23-CPN35217 Description/Approach Provider performance can vary widely in relation to efficiency and quality. Our goal as your Medicare health plan partner is to ensure our members receive high-quality care that leads to improved member health outcomes across a wide range of variables. We will add a new sorting option on the Find Care tool for members to leverage when they are searching for a non-PCP specialist provider. This sorting option, called Personalized Match Phase 1, is based on each provider’s score relative to their peers in the patient’s preferred mileage search radius. Providers will be listed in order of their total score, though no individual scores will appear within the tool or be visible to the covered patients. The Personalized Match Phase 1 algorithm will be based on quality and efficiency criteria to assist members in making more informed choices about their medical care. Other sorting options will still be available on Find Care for our members. Members should consider a variety of factors when making decisions for choosing a specialist provider to manage their care. We evaluate provider groups and individual providers annually, using updated quality and efficiency methodologies and data. Continue reading the rest of this article * Optum is an independent company providing assessment and reporting services on behalf of the health plan. CABC-CR-032269-23-CPN32264 ATTACHMENTS (available on web): Personalized Match Phase 1: Specialist Provider Overview (pdf - 0.64mb) We understand that providing the information needed to process a claim can cause payment delays, and the manual methods associated with mailing letters and returning information non-digitally is costly and inefficient. We’re changing that by implementing a new process: Digital Request for Additional Information (Digital RFAI), and we’re inviting you to participate. Digital requests for additional information are 50% faster than returning documentation any other way — making it the most efficient way to receive and return information — resulting in faster claim payments. Participation in Digital RFAI is easy- Registration:
- Your organization’s Availity* administrator will register for Medical Attachments:
- This enables you to receive digital notices (instead of paper) and to attach the requested documents directly to your claim.
- Ensure all of your billing NPIs/TINs are registered.
- User roles:
- Your Availity administrator will also update or add new users with these specific role assignments through Availity Essentials:
- Claims Status
- Medical Attachments
- This enables the users to view the Availity Attachment Dashboard.
- Ready to go:
- After the registration and user roles are completed on Availity, the Digital RFAI process is ready to go.
- Requests will automatically appear on the Attachments Dashboard each morning (when documents are needed).
Additional supportYou, your organization’s Availity administrator, or other members of your team may need additional support – and we’re to help: - For Availity Administrators: Take this training to ensure your NPIs are registered properly.
- For those sending attachments: Take this user training to learn about accessing notifications, sorting and filtering, and other enhancements that improve your experience.
Through our efforts, we are committed to reducing administrative burden and ensuring timely payments because we value you, our care provider partner. For additional resources, visit the Digital RFAI webpage or contact your Provider Relations Account Manager. * Availity, LLC is an independent company providing administrative support services on behalf of the health plan. CABC-CM-036132-23-CPN35203 Anthem continues to work to enhance our provider data management system, which should significantly improve your data accuracy, transparency, and experience. In May 2023, we mailed letters notifying our care provider partners about our plans to begin implementing changes to our data management system. Since that time, we’ve included reminders in our provider newsletter — Provider News. We will begin phasing in these changes this month —September 2023. What is important?- As a reminder, you are contractually required to report any practice changes.
- Tell us when providers join your group. Notifying us in a timely manner prior to the new provider rendering care to our members is important.
- Ensure all your contracted providers’ information is uploaded into our provider data management system prior to rendering services.
- Claims received for services rendered by a provider who has not yet been added to your contract will be rejected or processed as out of network.
What you need to know about billingAs part of this data management system upgrade, Anthem is applying the Centers for Medicare & Medicaid Services (CMS) billing guidelines to hold providers accountable for billing claims data correctly. Beginning in early 2024, claims submitted using rendering providers who have not been added to your contract by the date of service billed, or with missing or incorrect National Provider Identifiers (NPIs), will be rejected for more information or processed as out of network. Other important and helpful remindersSubmitting claims with complete and correct information is critical to ensuring Anthem can process your claims efficiently and accurately: - Bill according to standard billing guidelines.
- Review your billing practices carefully to ensure the proper tax identification number (TIN), NPI, and rendering provider information (if applicable) are submitted correctly.
More information is available online at anthem.com/ca/provider/policies. CMS regulations and guidance can be found here. Register today for the youth mental health forum hosted by Anthem and Motivo* for Anthem providers on September 27, 2023. Wednesday, September 27, 2023 3:30 to 5 p.m. Eastern time This important event will address the critical need to engage young people in leading their mental health. By deepening the discussion on youth mental health, we can do our part to foster a culture of understanding and support for youth and young adults. Authentic conversations lead to reducing implicit bias and improving the health and wellbeing of all Americans and the communities in which we live and serve. Please join us to hear from a diverse panel of experienced professionals and young leaders as we explore the challenges experienced by today’s youth, amplify the experiences and ideas of young people, and equip attendees with practical tools and innovative approaches to create meaningful change. Each forum will continue the exploration of ways we can reduce disparities in healthcare, demonstrate cultural humility, address, and deconstruct bias, have difficult and productive conversations, learn about valuable resources, increase inclusion, advance equity in healthcare. Please register for this event by visiting this link. * Motivo is an independent company providing a virtual forum on behalf of the health plan. CABC-CDCRCM-029398-23-CPN29379 On August 19, 2022, September 15, 2022, November 18, 2022, December 22, 2022, May 2, 2023, and May 19, 2023, the Pharmacy and Therapeutic (P&T) Committee approved the following Clinical Criteria applicable to the medical drug benefit for Anthem Blue Cross (Anthem). These policies were developed, revised, or reviewed to support clinical coding edits. Visit Clinical Criteria to search for specific policies. If you have questions or need additional information, use this email. Please see the explanation/definition for each category of Clinical Criteria below: - New: Newly published criteria.
- Revised: Addition or removal of medical necessity requirements, new document number
- Updates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive.
Please share this notice with other providers in your practice and office staff. Please note: - The Clinical Criteria listed below applies only to the medical drug benefits contained within the member’s medical policy. This does not apply to pharmacy services.
- This notice is meant to inform the provider of new or revised criteria that has been adopted by Anthem only. It does not include details regarding any authorization requirements. Authorization rules are communicated via a separate notice.
Effective date | Clinical Criteria number | Clinical Criteria title | New or revised | November 8, 2023 | *CC-0237 | Qalsody (tofersen) | New | November 8, 2023 | *CC-0238 | Hydroxyprogesterone caproate | New | November 8, 2023 | *CC-0240 | Zynyz (retifanlimab-dlwr) | New | November 8, 2023 | CC-0165 | Trodelvy (sacituzumab govitecan) | Revised | November 8, 2023 | CC-0002 | Colony Stimulating Factor Agents | Revised | November 8, 2023 | CC-0128 | Tecentriq (atezolizumab) | Revised | November 8, 2023 | CC-0098 | Doxorubicin Liposome (Doxil, Lipodox) | Revised | November 8, 2023 | CC-0101 | Torisel (temsirolimus) | Revised | November 8, 2023 | CC-0107 | Bevacizumab for Non-Ophthalmologic Indications | Revised | November 8, 2023 | CC-0143 | Polivy (polatuzumab vedotin-piiq) | Revised | November 8, 2023 | CC-0092 | Adcetris (brentuximab vedotin) | Revised | November 8, 2023 | CC-0095 | Velcade (bortezomib) | Revised | November 8, 2023 | CC-0105 | Vectibix (panitumumab) | Revised | November 8, 2023 | CC-0178 | Synribo (omacetaxine mepesuccinate) | Revised | November 8, 2023 | CC-0114 | Jevtana (cabazitaxel) | Revised | November 8, 2023 | CC-0145 | Libtayo (cemiplimab-rwlc) | Revised | November 8, 2023 | *CC-0032 | Botulinum Toxin | Revised | November 8, 2023 | CC-0068 | Growth Hormone | Revised | November 8, 2023 | *CC-0057 | Krystexxa (pegloticase) | Revised | November 8, 2023 | *CC-0125 | Opdivo (nivolumab) | Revised | November 8, 2023 | *CC-0225 | Tzield (teplizumab-mzwv) | Revised | November 8, 2023 | *CC-0167 | Rituximab Agents for Oncologic Indications | Revised | November 8, 2023 | *CC-0075 | Rituximab Agents for Non-Oncologic Indications | Revised | November 8, 2023 | *CC-0182 | Iron Agents | Revised | November 8, 2023 | *CC-0124 | Keytruda (pembrolizumab) | Revised |
CABC-CD-031927-23-CPN30759 On December 22, 2022, May 2, 2023, and May 19, 2023, the Pharmacy and Therapeutic (P&T) Committee approved the following Clinical Criteria applicable to the medical drug benefit for Anthem Blue Cross (Anthem). These policies were developed, revised, or reviewed to support clinical coding edits. Visit Clinical Criteria to search for specific policies. If you have questions or need additional information, use this email. Please see the explanation/definition for each category of Clinical Criteria below: - New: Newly published criteria
- Revised: Addition or removal of medical necessity requirements, new document number
- Updates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive.
Please share this notice with other providers in your practice and office staff. Please note: - The Clinical Criteria listed below applies only to the medical drug benefits contained within the member’s medical policy. This does not apply to pharmacy services.
- This notice is meant to inform the provider of new or revised criteria that has been adopted by Anthem only. It does not include details regarding any authorization requirements. Authorization rules are communicated via a separate notice.
Effective date | Clinical Criteria number | Clinical Criteria title | New or revised | September 11, 2023 | *CC-0237 | Qalsody (tofersen) | New | September 11, 2023 | *CC-0238 | Hydroxyprogesterone caproate | New | September 11, 2023 | *CC-0240 | Zynyz (retifanlimab-dlwr) | New | September 11, 2023 | CC-0165 | Trodelvy (sacituzumab govitecan) | Revised | September 11, 2023 | CC-0002 | Colony Stimulating Factor Agents | Revised | September 11, 2023 | CC-0128 | Tecentriq (atezolizumab) | Revised | September 11, 2023 | CC-0098 | Doxorubicin Liposome (Doxil, Lipodox) | Revised | September 11, 2023 | CC-0101 | Torisel (temsirolimus) | Revised | September 11, 2023 | CC-0107 | Bevacizumab for Non-Ophthalmologic Indications | Revised | September 11, 2023 | CC-0143 | Polivy (polatuzumab vedotin-piiq) | Revised | September 11, 2023 | CC-0092 | Adcetris (brentuximab vedotin) | Revised | September 11, 2023 | CC-0095 | Velcade (bortezomib) | Revised | September 11, 2023 | CC-0105 | Vectibix (panitumumab) | Revised | September 11, 2023 | CC-0178 | Synribo (omacetaxine mepesuccinate) | Revised | September 11, 2023 | CC-0114 | Jevtana (cabazitaxel) | Revised | September 11, 2023 | CC-0145 | Libtayo (cemiplimab-rwlc) | Revised | September 11, 2023 | *CC-0032 | Botulinum Toxin | Revised | September 11, 2023 | CC-0068 | Growth Hormone | Revised | September 11, 2023 | *CC-0057 | Krystexxa (pegloticase) | Revised | September 11, 2023 | *CC-0125 | Opdivo (nivolumab) | Revised | September 11, 2023 | *CC-0225 | Tzield (teplizumab-mzwv) | Revised | September 11, 2023 | *CC-0124 | Keytruda (pembrolizumab) | Revised |
CABC-CR-031948-23-CPN30755 Effective December 1, 2023, prior authorization (PA) requirements will change for the following code(s). The medical code(s) listed below will require PA by Anthem Blue Cross for Medicaid members. Federal and state law, as well as state contract language and Centers for Medicare & Medicaid Services guidelines, including definitions and specific contract provisions/exclusions take precedence over these PA rules and must be considered first when determining coverage. Non-compliance with new requirements may result in denied claims. Prior authorization requirements will be added for the following code(s): Code | Code description | 69705 | Nasopharyngoscopy, surgical, with dilation of eustachian tube (in other words, balloon dilation); unilateral | 69706 | Nasopharyngoscopy, surgical, with dilation of eustachian tube (in other words, balloon dilation); bilateral |
To request PA, you may use one of the following methods: - Web: Once logged in to Availity* at availity.com.
- Fax: 800-754-4708
- Phone: 888-831-2246 (Medi-Cal) 877-273-4193 (MRMIP)
Not all PA requirements are listed here. Detailed PA requirements are available to providers on providers.anthem.com/ca on the Resources tab or for contracted providers by accessing Availity.com. Providers may also call one of our Customer Care Centers at 800-407-4627 (outside L.A. Count) or 888-285-7801 (inside L.A. County) for assistance with PA requirements. * Availity, LLC is an independent company providing administrative support services on behalf of the health plan.
UM AROW #4500 CABC-CD-028260-23-CPN27261 Effective December 1, 2023, prior authorization (PA) requirements will change for the following code(s). The medical code(s) listed below will require PA by Anthem Blue Cross for Medicare members. Federal and state law, as well as state contract language and Centers for Medicare & Medicaid Services guidelines, including definitions and specific contract provisions/exclusions take precedence over these precertification rules and must be considered first when determining coverage. Non-compliance with new requirements may result in denied claims. Prior authorization requirements will be added for the following code(s): Code | Code description | 64581 | Incision for implantation of neurostimulator electrode array; sacral nerve (transforaminal placement) | 64628 | Thermal destruction of intraosseous basivertebral nerve, including all imaging guidance; first 2 vertebral bodies, lumbar or sacral | C1764 | Event recorder, cardiac (implantable) | E0466 | Home ventilator, any type, used with non-invasive interface, (for example, mask, chest shell) | E0766 | Electrical stimulation device used for cancer treatment, includes all accessories, any type | L5845 | Knee-Shin Sys Stance Flexion | L5910 | Endo Below Knee Alignable Sy |
Not all PA requirements are listed here. Detailed PA requirements are available to providers on anthem.com/ca/provider/medicare-advantage on the Resources tab or for contracted providers by accessing Availity.com.* Providers may also call the number on the back of the member’s ID card for assistance with PA requirements. * Availity, LLC is an independent company providing administrative support services on behalf of the health plan.
UM AROW# 4489 CABC-CR-028200-23-CPN27653 Effective for dates of service on and after December 1, 2023, the following codes will require prior authorization through Carelon Medical Benefits Management, Inc.* (formerly AIM Specialty Health®). CPT® code | Description | 0042T | Cerebral Perfusion Analysis Using Computed Tomography with Contrast Administration, Including Post-Processing of Parametric Maps with Determination of Cerebral Blood Flow, Cerebral Blood Volume, and Mean Transit Time |
As a reminder, ordering and servicing providers may submit prior authorization requests to Carelon in one of several ways: - Access Carelon’s ProviderPortalSM directly at www.providerportal.com:
- Online access is available 24/7 to process orders in real-time and is the fastest and most convenient way to request authorization.
- Access Carelon via the Availity Essentials* website at www.availity.com.
Note: This update does not apply to the Federal Employee Program®. If you have any questions related to guidelines, please contact Carelon via email at MedicalBenefitsManagement.guidelines@Carelon.com. Additionally, you may access and download a copy of the current and upcoming guidelines here. * Carelon Medical Benefits Management, Inc. is an independent company providing utilization management services on behalf of the health plan. Availity, LLC is an independent company providing administrative support services on behalf of the health plan. CABC-CR-025219-23-CPN25171 Your Dual-Eligible Special Needs Plan (DSNP) member’s Individualized Care Plan (ICP/CP) is available on Availity* at www.availity.com. We would like the opportunity to discuss identified problems/needs and collaborate on ways to assist the member in meeting their care plan goals. The member and/or caregiver are central to the process and are also invited to attend the Interdisciplinary Care Team (ICT) meeting. Your participation is important. If you would like to participate in the ICT meeting, call us back as soon as possible at 844-408-6568. When contacting us, include the member’s name, date of birth, and Medicare identification number. The case manager will reach out to set up the meeting. Any care plan changes made from the ICT meeting will be available for you to review on Availity one-to-two working days after the meeting. To access the care plan information, your Availity administrator must register you for access to Member Clinical Reports and complete the registration process using Payer Spaces > Preference Center. Once the registration piece is complete, log in to Availity, select Payer Spaces > Payer Tile > Alerts Hub to access the member’s ICP. We are available Monday through Friday, 8 a.m. to 5 p.m., excluding holidays. * Availity, LLC is an independent company providing administrative support services on behalf of the health plan. CABC-CR-024212-23-CPN23812 Effective April 5, 2023, Sublocade® can no longer be filled at Accredo Specialty Pharmacy.* Members currently filling through Accredo Specialty Pharmacy will need to switch to CVS Specialty Pharmacy.* A member of the CVS Specialty Pharmacy Care team will be contacting prescribers to obtain a new prescription. Prescribers can contact CVS Specialty Pharmacy at 877-254-0015. * Accredo Specialty Pharmacy is an independent company providing pharmacy services on behalf of the health plan. CVS is an independent company providing pharmacy services on behalf of the health plan. CABC-CM-034782-23-CPN34761 The following Part B medications from the current Clinical Criteria Guidelines are included in our medical step therapy precertification review process. Step therapy review will apply upon precertification initiation, in addition to the current medical necessity review (as is current procedure). Step therapy will not apply for members who are actively receiving medications listed below. There are no clinical changes to Clinical Criteria CC-005, Hyaluronan Injections. Based on feedback, the table listing the preferred and non-preferred products has been updated to present the information in a more useful manner. The updated table identifies preferred alternatives based on injection series. Clinical Criteria Guidelines are publicly available on the provider website. Visit the Clinical Criteria page to search for specific criteria. Clinical UM Guidelines | Preferred drug(s) | Nonpreferred drug(s) | CC-0005 | Single injection: Durolane Three injection series: Euflexxa Gel-Syn Five injection series: Supartz | Single injection: Gel-One Monovisc Synvisc-one Two injection series: Hymovis Three Injection series: Orthovisc Synojoynt Synvisc Triluron Trivisc Five injection series: Genvisc 850 Hyalgan Visco-3 |
CABC-CR-031132-23-CPN30365 **This collateral ran originally in the July 1, 2023, newsletter and was also posted on the provider portal with an October 1, 2023, effective date. The new date of service will begin on November 1, 2023.** Effective for dates of service on and after November 1, 2023, the specialty Medicare Part B drug listed in the table below will be included in our precertification review process. Federal and state law, as well as state contract language and CMS guidelines, including definitions and specific contract provisions/exclusions, take precedence over these precertification rules and must be considered first when determining coverage. Noncompliance with new requirements may result in denied claims. HCPCS or CPT® codes | Medicare Part B drugs | J1931 | Aldurazyme (laronidase) | J0256 | Aralast NP (alpha-1 proteinase inhibitor), Prolastin-C (alpha-1 proteinase inhibitor), Zemaira (alpha-1 proteinase inhibitor) | J1786 | Cerezyme (imiglucerase) | J0584 | Crysvita (burosumab-twza) | J1743 | Elaprase (idursulfase) | J3060 | Elelyso (taliglucerase) | J0180 | Fabrazyme (agalsidase beta) | J0257 | Glassia (alpha-1 proteinase inhibitor) | J0638 | Ilaris (canakinumab) | J0221 | Lumizyme (alglucosidase alfa) | J3397 | Mepsevii (vestronidase alfa) | J1458 | Naglazyme (galsulfase) | J0219 | Nexviazyme (avalglucosidase alfa-ngpt) | J0222 | Onpattro (patisiran) | J1322 | Vimizim (elosulfase alfa) | J3385 | Vpriv (velaglucerase) | J0775 | Xiaflex (collagenase clostridium histolyticum) |
CABC-CR-032239-23-CPN31947 Prior authorization updates for medications billed under the medical benefit Effective for dates of service on and after September 1, 2023, the following medication codes billed on medical claims will require prior authorization in accordance with the requirements of the current or new Clinical Criteria documents. Please note, inclusion of a national drug code on your medical claim is necessary for claims processing. Visit the Clinical Criteria website to search for the following specific Clinical Criteria listed. Clinical Criteria | HCPCS or CPT® code(s) | Drug name | CC-0065 | C9399, J7199 | Altuviiio (antihemophilic factor recombinant) |
What if I need assistance?If you have questions about this communication or need assistance with any other item, contact your local Provider Relationship Management representative or call one of our Medi-Cal Managed Care Customer Care Centers: - Outside L.A.: 800-407-4627
- Inside L.A.: 888-285-7801
Note: Prior authorization requests for certain medications may require additional documentation to determine medical necessity. CABC-CD-028794-23-CPN28733 PurposeThe purpose of this bulletin is to provide guidance on the provision of an annual Medi-Cal cognitive health assessment for members 65 years of age or older. BackgroundCalifornia Senate Bill (SB) 48 (Chapter 484, Statutes of 2021) expands the Medi-Cal schedule of benefits to include an annual cognitive assessment for Medi-Cal members who are 65 years of age and older if they are otherwise ineligible for a similar assessment as part of an annual wellness visit through the Medicare program, subject to an appropriation by the state legislature for this purpose as of July 1, 2022. The annual cognitive health assessment is intended to identify whether the patient has signs of Alzheimer’s disease or related dementias, consistent with the standards for detecting cognitive impairment under the Medicare annual wellness visit and the recommendations by the American Academy of Neurology. Additionally, SB 48 outlines requirements that Medi-Cal providers must complete prior to being eligible to receive payment for conducting annual cognitive health assessments. Medi-Cal providers must complete training as specified and approved by the Department of Health Care Services (DHCS) and use validated tools recommended by the DHCS. PolicyThe annual cognitive health assessment is for members 65 years of age or older who do not have Medicare coverage. Trained providers who render the assessment will bill with CPT® code 1494F. The code is allowable once per year as part of the member’s annual exam. CPT code | Description | Directed payment | 1494F | Cognitive health assessment performed | $29 |
Provider billing requirementsTo appropriately bill and receive reimbursement for conducting an annual cognitive health assessment, providers must do all of the following: - Complete the DHCS Dementia Care Aware cognitive health assessment training (dementiacareaware.org) prior to conducting the brief cognitive health assessment:
- Anthem Blue Cross (Anthem) will have access to a list of providers who have completed the training.
- Administer the annual cognitive health assessment as a component of an evaluation and management visit including but not limited to an office visit, consultation, or preventative medicine service (elements of the cognitive health assessment can be conducted by non-billing team members acting within their scope of practice and under the supervision of the billing provider).
- Document all the following in the member’s medical records and have such records available upon request:
- The screening tool or tools that were used (at least one tool from the cognitive assessment tools section below is required)
- Verification that screening results were viewed by the provider
- The results of the screening
- The interpretation of results
- Details discussed with the member and/or authorized representative and any appropriate actions taken regarding screening results
- Use CPT code 1494F as outlined in the Medi-Cal Provider Manual. For further assistance, contact your Provider Relationship Management associate.
Cognitive assessment toolsAt least one cognitive assessment tool listed below is also required. Cognitive assessment tools used to determine if a full dementia evaluation is needed include, but are not limited to: - Patient assessment tools:
- General Practitioner Assessment of Cognition (GPCOG)
- Mini-Cog
- Informant tools (family members and close friends):
- Eight-Item Informant Interview to Differentiate Aging and Dementia
- GPCOG
- Informant Questionnaire on Cognitive Decline in the Elderly
Medical record reviewsTo ensure the provision of appropriate and necessary follow-up services based on assessment scores, including but not limited to additional assessment or specialist referrals, the plan may conduct random medical record reviews. Members under 65 years of ageAnthem will cover medically necessary and appropriate coverage of assessments for members under 65 years of age who are reporting symptoms or showing signs of cognitive decline. This may include but is not limited to cognitive health assessments, appropriate treatment services, and necessary referrals billed through established practices. ResourcesProviders can view the required training at dementiacareaware.org. Anthem Blue Cross (Anthem) reimburses providers for Medicare Advantage medication reconciliation. Please see the FAQ to learn how to receive reimbursement for post inpatient discharge medication reconciliation. |